Sign in

CIK 0001133416 · Non-accelerated filer<br>Smaller reporting company

GALECTIN THERAPEUTICS INC

Sign in to watch
Ticker
GALT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
operating
EIN
043562325
Phone
678-620-3186
Business address
4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GA, 30071
Former names
PRO PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-01-24 Schwartz Elissa J. Director Grant or award · Stock Option (right to buy) +50,000 50,000
2024-01-24 Rubin Marc Director Grant or award · Stock Option (right to buy) +50,000 50,000
2024-01-24 OMENN GILBERT S Director Grant or award · Stock Option (right to buy) +50,000 50,000
2024-01-24 LEWIS JOEL President and CEO Grant or award · Stock Option (right to buy) +91,000 91,000
2024-01-24 LEWIS JOEL President and CEO Grant or award · Restricted Stock Unit +56,000 56,000
2024-01-24 FREEMAN KEVIN D Director Grant or award · Stock Option (right to buy) +50,000 50,000
2024-01-24 ELDRED KARY Director Grant or award · Stock Option (right to buy) +50,000 50,000
2024-01-24 CARSON BENJAMIN SR Director Grant or award · Stock Option (right to buy) +50,000 50,000
2024-01-24 CALLICUTT JACK W Chief Financial Officer Grant or award · Stock Option (right to buy) +65,000 65,000
2024-01-24 CALLICUTT JACK W Chief Financial Officer Grant or award · Restricted Stock Unit +40,000 40,000
2024-01-16 ELDRED KARY Director Purchase +400 $2.39 $956 49,713

Page 15 of 15 · 291 trades